Qube Research & Technologies (QRT)
CLOV icon

Qube Research & Technologies (QRT)’s Clover Health Investments CLOV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-368,065
Closed -$1.13M – 3712
2025
Q3 		$1.13M Sell
368,065
-1,746,937
-83% -$4.99M ﹤0.01% 2461
2025
Q2 		$5.9M Sell
2,115,002
-2,210,707
-51% -$7.27M 0.01% 1605
2025
Q1 		$15.5M Sell
4,325,709
-382,053
-8% -$1.53M 0.02% 874
2024
Q4 		$14.8M Buy
4,707,762
+1,949,126
+71% +$6.97M 0.02% 861
2024
Q3 		$7.78M Buy
2,758,636
+737,827
+37% +$1.69M 0.01% 1181
2024
Q2 		$2.49M Sell
2,020,809
-406,687
-17% -$365K ﹤0.01% 1531
2024
Q1 		$1.93M Sell
2,427,496
-326,618
-12% -$297K ﹤0.01% 1784
2023
Q4 		$2.62M Buy
2,754,114
+1,399,773
+103% +$1.37M 0.01% 1393
2023
Q3 		$1.46M Buy
1,354,341
+131,242
+11% +$156K ﹤0.01% 1552
2023
Q2 		$1.1M Sell
1,223,099
-166,817
-12% -$148K ﹤0.01% 1268
2023
Q1 		$1.17M Buy
1,389,916
+165,216
+13% +$181K 0.01% 1225
2022
Q4 		$1.14M Buy
1,224,700
+454,606
+59% +$607K 0.01% 1173
2022
Q3 		$1.31M Buy
770,094
+493,989
+179% +$1.29M 0.01% 1095
2022
Q2 		$591K Sell
276,105
-520,506
-65% -$1.38M ﹤0.01% 1344
2022
Q1 		$2.83M Sell
796,611
-3,780
-0.5% -$11K 0.02% 690
2021
Q4 		$2.98M Buy
+800,391
New +$4.91M 0.02% 701
2021
Q3 		– Sell
-168,182
Closed -$2.24M – 2271
2021
Q2 		$2.24M Buy
+168,182
New +$1.65M 0.03% 660
2021
Q1 		– Sell
-23,416
Closed -$393K – 1969
2020
Q4 		$393K Buy
+23,416
New +$261K 0.01% 1242

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLOV Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Clover Health Investments (CLOV) in Q4 2025, closing a stake of 368,065 shares — an estimated $1.13M sold.

Qube Research & Technologies (QRT) first reported a position in CLOV in Q4 2020 and held it in 18 quarters. The position peaked at $15.5M in Q1 2025. 192 funds tracked by Wall St. Rank hold CLOV as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Clover Health Investments position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 368,065 Clover Health Investments shares in Q4 2025, an estimated $1.13M.
  • Qube Research & Technologies (QRT) first reported a position in Clover Health Investments in Q4 2020 and held it in 18 quarters.
  • Qube Research & Technologies (QRT)'s Clover Health Investments position peaked at $15.5M in Q1 2025.
  • 192 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.